Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy

First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Japan.

OBJECTIVES: This study attempted to assess myocardial sympathetic innervation using iodine-123 (I-123) metaidobenzylguanidine (MIBG) imaging in patients with familial amyloid polyneuropathy. BACKGROUND: Signs and symptoms of cardiac autonomic dysfunction are commonly seen in patients with cardiac amyloidosis. However, the incidence and magnitude of abnormalities in myocardial sympathetic nerve function by means of I-123 MIBG imaging and their relation to clinical findings, cardiac function and the results of thallium-201 (Tl-201) and technetium-99m pyrophosphate (Tc-99m PYP) myocardial scanning have not yet been clarified. METHODS: We performed M-mode, two-dimensional and Doppler echocardiography and I-123 MIBG, Tl-201 and Tc-99m PYP imaging of the heart in 12 patients with familial amyloid polyneuropathy and biopsy-proved cardiac amyloidosis. RESULTS: Ten of 12 patients had no clinical evidence of overt heart disease, but left ventricular (LV) wall thickening was observed in 4 of these 10. Left ventricular percent fractional shortening and Doppler transmitral flow velocity patterns were found to be normal in all 12 patients. Eight of 12 patients showed no myocardial MIBG accumulation, with limited uptake in the remaining 4 demonstrated only in the LV anterior wall. Diffuse but mild myocardial uptake of Tc-99m PYP occurred in only 4 of 12 patients, and all 12 had normal results on Tl-201 myocardial scanning. Complete defects on myocardial MIBG scans were found in five of eight patients with negative findings on Tc-99m PYP myocardial scanning. The incidence and magnitude of myocardial uptake of MIBG were independent of clinical findings, extent of endomyocardial amyloid deposition, electrocardiographic QRS voltage and ventricular wall thickness. CONCLUSIONS: Patients with familial amyloid polyneuropathy show a high incidence of myocardial adrenergic denervation with viable myocardium that can be identified very early in cardiac amyloidosis, before the development of clinically apparent heart disease, ventricular wall thickening, significant LV systolic and diastolic dysfunction and positive findings on Tc-99m PYP myocardial scanning.

This article has been cited by other articles:

				C. Rapezzi, C. C. Quarta, P. L. Guidalotti, C. Pettinato, S. Fanti, O. Leone, A. Ferlini, S. Longhi, M. Lorenzini, L. B. Reggiani, et al. Role of 99mTc-DPD Scintigraphy in Diagnosis and Prognosis of Hereditary Transthyretin-Related Cardiac Amyloidosis J. Am. Coll. Cardiol. Img., June 1, 2011; 4(6): 659 - 670. [Abstract] [Full Text] [PDF]

				R. Y. Kwong and R. H. Falk Cardiovascular Magnetic Resonance in Cardiac Amyloidosis Circulation, January 18, 2005; 111(2): 122 - 124. [Full Text] [PDF]

				Committee Members, F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1318 - 1333. [Full Text] [PDF]

				F. J. Klocke, M. G. Baird, B. H. Lorell, T. M. Bateman, J. V. Messer, D. S. Berman, P. T. O'Gara, B. A. Carabello, R. O. Russell Jr, M. D. Cerqueira, et al. ACC/AHA/ASNC Guidelines for the Clinical Use of Cardiac Radionuclide Imaging--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging) Circulation, September 16, 2003; 108(11): 1404 - 1418. [Full Text] [PDF]

				N. Delahaye, D. Le Guludec, S. Dinanian, J. Delforge, M. S. Slama, L. Sarda, F. Dolle, H. Mzabi, D. Samuel, D. Adams, et al. Myocardial Muscarinic Receptor Upregulation and Normal Response to Isoproterenol in Denervated Hearts by Familial Amyloid Polyneuropathy Circulation, December 11, 2001; 104(24): 2911 - 2916. [Abstract] [Full Text] [PDF]

				T. Koizumi, K. Kubo, M. Hanaoka, H. Yamamoto, S. Yamaguchi, T. Fujii, and T. Kobayashi Serial Scintigraphic Assessment of Iodine-123 Metaiodobenzylguanidine Lung Uptake in a Patient With High-Altitude Pulmonary Edema Chest, October 1, 1999; 116(4): 1129 - 1131. [Abstract] [Full Text] [PDF]

				D. RUBINGER, D. SAPOZNIKOV, A. POLLAK, M. M. POPOVTZER, and M. H. LURIA Heart Rate Variability during Chronic Hemodialysis and after Renal Transplantation: Studies in Patients without and with SystemicAmyloidosis J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1972 - 1981. [Abstract] [Full Text]

				M HONGO and M SEKIGUCHI Familial and primary cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes Heart, March 1, 1998; 79(3): 313a - 313. [Full Text]